Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study

Abstract Background: The optimal treatment for bloodstream infections (BSIs) with vancomycin-resistant enterococci (VRE) is unknown. Objective: This study examined outcomes in patients treated with daptomycin or linezolid for VRE BSI. Methods: A retrospective, multicenter, cohort study was performed...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical therapeutics 2010-09, Vol.32 (10), p.1713-1719
Hauptverfasser:	Crank, Christopher W., PharmD, Scheetz, Marc H., PharmD, Brielmaier, Benjamin, PharmD, Rose, Warren E., PharmD, Patel, Gourang P., PharmD, Ritchie, David J., PharmD, Segreti, John, MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetamides - administration & dosage Acetamides - therapeutic use Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - therapeutic use bacteremia Bacteremia - drug therapy Bacteremia - microbiology Bacterial diseases Bacterial sepsis Biological and medical sciences Cohort Studies daptomycin Daptomycin - administration & dosage Daptomycin - therapeutic use Data Interpretation, Statistical Enterococcus - drug effects Enterococcus - isolation & purification Gram-Positive Bacterial Infections - drug therapy Gram-Positive Bacterial Infections - microbiology Gram-Positive Bacterial Infections - mortality Human bacterial diseases Humans Infectious diseases Internal Medicine Linezolid Medical Education Medical sciences Multivariate Analysis outcomes Oxazolidinones - administration & dosage Oxazolidinones - therapeutic use Pharmacology. Drug treatments Prognosis resistance Retrospective Studies Treatment Outcome Vancomycin Resistance - drug effects vancomycin-resistant enterococcus
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!